canyon landscape

Eli Lilly I5Q-MC-B002

Preventive Treatment of Migraine: Outcomes for Patients in Real-World Healthcare Systems (TRIUMPH)

The purpose of this study is to collect information about treatment patterns, effects, and outcomes in patients with migraine who are switching or initiating a pharmacologic treatment for migraine prevention. 

We anticipate that approximately 6000 patients will participate in this study. 

Open and enrolling subjects.
Phoenix, Arizona
Total Participants
Primary Sponsor
Eli Lilly